Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

Cited In for PubMed (Select 10791523)

1.

Systemic effects of inhaled corticosteroids: an overview.

Pandya D, Puttanna A, Balagopal V.

Open Respir Med J. 2014 Dec 31;8:59-65. doi: 10.2174/1874306401408010059. eCollection 2014.

2.

TRIP-1: a regulator of osteoblast function.

Metz-Estrella D, Jonason JH, Sheu TJ, Mroczek-Johnston RM, Puzas JE.

J Bone Miner Res. 2012 Jul;27(7):1576-84. doi: 10.1002/jbmr.1611.

3.

Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review.

Peppa M, Krania M, Raptis SA.

Integr Blood Press Control. 2011;4:7-16. doi: 10.2147/IBPC.S9486. Epub 2011 Mar 3.

4.

Asthma and therapeutics: inhaled corticosteroids, corticosteroid osteoporosis, and the risk of fracture in chronic asthma.

Toogood JH.

Allergy Asthma Clin Immunol. 2005 Mar 15;1(1):28-33. doi: 10.1186/1710-1492-1-1-28. Epub 2005 Mar 15.

5.

Exacerbation rate, health status and mortality in COPD--a review of potential interventions.

Seemungal TA, Hurst JR, Wedzicha JA.

Int J Chron Obstruct Pulmon Dis. 2009;4:203-23. Epub 2009 Jun 11. Review.

6.
7.

Relative contributions of multiple determinants to bone mineral density in men.

Chiu GR, Araujo AB, Travison TG, Hall SA, McKinlay JB.

Osteoporos Int. 2009 Dec;20(12):2035-47. doi: 10.1007/s00198-009-0895-0. Epub 2009 Mar 25.

8.

Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study.

Kelly HW, Van Natta ML, Covar RA, Tonascia J, Green RP, Strunk RC; CAMP Research Group.

Pediatrics. 2008 Jul;122(1):e53-61. doi: 10.1542/peds.2007-3381.

9.

Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction.

Mortimer KJ, Tattersfield AE, Tang Y, Wu K, Lewis S, Hochhaus G, Harrison TW.

Br J Clin Pharmacol. 2007 Oct;64(4):439-44. Epub 2007 Aug 15.

10.

Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment.

Popp AW, Isenegger J, Buergi EM, Buergi U, Lippuner K.

Eur Spine J. 2006 Jul;15(7):1035-49. Review.

11.
12.

Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids.

Campbell IA, Douglas JG, Francis RM, Prescott RJ, Reid DM; Research Committee of the British Thoracic Society.

Thorax. 2004 Sep;59(9):761-8.

13.

Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide.

Phillips K, Oborne J, Lewis S, Harrison TW, Tattersfield AE.

Thorax. 2004 Jan;59(1):26-30.

14.

A population based case-control study of cataract and inhaled corticosteroids.

Smeeth L, Boulis M, Hubbard R, Fletcher AE.

Br J Ophthalmol. 2003 Oct;87(10):1247-51.

15.

Medical treatment of vertebral osteoporosis.

Lippuner K.

Eur Spine J. 2003 Oct;12 Suppl 2:S132-41. Epub 2003 Sep 17. Review.

16.

Stepping down inhaled corticosteroids in asthma: randomised controlled trial.

Hawkins G, McMahon AD, Twaddle S, Wood SF, Ford I, Thomson NC.

BMJ. 2003 May 24;326(7399):1115.

17.

Pharmacokinetics and systemic effects of inhaled fluticasone propionate in chronic obstructive pulmonary disease.

Singh SD, Whale C, Houghton N, Daley-Yates P, Kirby SM, Woodcock AA.

Br J Clin Pharmacol. 2003 Apr;55(4):375-81.

19.

Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years.

Tattersfield AE, Town GI, Johnell O, Picado C, Aubier M, Braillon P, Karlström R.

Thorax. 2001 Apr;56(4):272-8.

20.

The ISOLDE trial. Side effects with inhaled steroids should not be forgotten.

Lipworth BJ.

BMJ. 2000 Nov 25;321(7272):1349. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk